- ANZ New Zealand CEO steps down after personal expenses review
- RBS reports impact of Alawwal Bank and Saudi British Bank merger
- SEC fines Industrial and Commercial Bank of China affiliate for improper handling of ADRs
- UK smaller businesses received a record £6.7bn equity finance investment in 2018
- Banks and payment providers need to get their IT act together, says KCOM
- Fifth of UK investors looking to debt investment, new research reveals
- allpay.cards joins Fintech consortium to drive banking innovation expired
- Mobile payments to expand from $348bn to just under $1.3trn by 2022, finds report expired
- Lloyds launches Open Banking app for credit card and savings customers expired
- The next Bitcoin run is imminent, says deVere CEO expired
- First-time buyer and home-mover numbers on the up, finds UK Finance expired
- CMA drops Non-Standard Finance/Provident Financial merger inquiry expired
9th October 2018
World's first shared trading platform available for public beta test
The world's first shared trading platform, Exchain, has rolled out its public beta test. Exchain aims to build a transparent, open and mutually beneficial trading platform that is co-owned, shared and governed by the public and features shared benefits, monitoring and transaction transparency.
In order to better create a shared trading platform, Exchain comes with several features: the transaction is a form of investment in the platform; no transaction fees for the first three months; availability of partner programmes; and the ability to issues ICOs that will never be subject to listing fees. These features set up a scenario whereby both the project developer and the users of the exchange can participate in co-ownership, sharing and co-governance.
Exchain adopted the "transaction is a form of investment" model, in which users can, through trading, obtain the platform token, ET, and become a shareholder in Exchain, as well as share in the benefits and interests of Exchain. Exchain has also launched trading with no transaction fees for the first three months.